China Medical Technologies Spends $345M for Rights to HPV Testing Platform | GenomeWeb
NEW YORK (GenomeWeb News) – China Medical Technologies said yesterday that it had entered into a definitive agreement to acquire a molecular diagnostic test for human papillomavirus and an analysis platform from Molecular Diagnostic Technologies for $345 million.
 
The Beijing-based firm said that it will acquire the HPV-DNA Biosensor Chip and a surface plasmon resonance-based system for detecting the virus.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.